Newly Researched Infertility Treatment Comes to the Western U.S.
Posted on: Monday, 25 July 2005, 15:01 CDT
NEWPORT BEACH, Calif., July 25 /PRNewswire/ -- A new infertility treatment, shown to be effective without drugs or surgery, is now available in the Western U.S. The therapy, known as the Wurn Technique(R) (patent pending), is a manual physical therapy, similar to massage.
Previously available only in the Eastern U.S., the therapy has been used as an adjunct to traditional infertility treatments for several years. It is now being offered at Clear Passage Therapies(R) in Orange County, California, between Los Angeles and San Diego. (See http://www.clearpassage.com/ ). The new clinic will provide a valuable service for the nearly one in six couples throughout the Western U.S. who are struggling with infertility.
Medical studies published in "Medscape General Medicine, Ob/Gyn & Women's Health" (6/04) show the therapy significantly increased pregnancy rates for women diagnosed infertile. Study participants who received therapy before undergoing in vitro fertilization (IVF) saw pregnancy rates climb to 67%, far above the 41% national average for IVF, as reported by the US Centers for Disease Control. "I am always looking for new approaches to benefit my patients' goals of becoming parents," said Brian Acacio, MD, Medical Director of Sher Institute for Reproductive Medicine, Los Angeles. "This preliminary research shows improvement with this therapy. While additional studies need to be conducted, this is very exciting."
In a related study, 71% of infertile women conceived naturally after therapy. "The therapy appears to facilitate fertility in women with a wide array of unexplained or adhesion-related infertility," said Richard King, MD, an independent gynecologist and research physician. "Prior to receiving the therapy, patients in the natural therapy study reported infection, surgery, endometriosis, hormonal issues, unexplained infertility, and even blocked fallopian tubes. Most became pregnant naturally and delivered babies following therapy." Women in both studies averaged 5 years of infertility.
No drugs or surgery are used with the therapy and side effects are generally positive. A third study published in Medscape (12/04) reported the therapy's effectiveness in reducing intercourse pain and increasing sexual function in areas measurable by science, including desire [libido] and orgasm.
"I am pleased to offer this new therapy on the West Coast," said Mary Cox, PT, Director of the Newport Beach clinic. "I look forward to working with women and their physicians to resolve pelvic pain, and to improve success rates for infertility patients."
Clear Passage is accepting patients for treatment and offering phone consultations (at no charge) toll free at 1-866-BABYHERE (1-866-222-9437). Clinics are currently located in Florida, Iowa, California and New York with plans to open in Arizona later this year. More information is available at http://www.clearpassage.com/ .
For further information contact: Anna Waldthausen at 917.403.6200 anna@clearpassage.com
Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Belinda Wurn http://profnet.prnewswire.com/ud_public.jsp?userid=513607
Clear Passage Therapies
CONTACT: Anna Waldthausen, Clear Passage Therapies, +1-917-403-6200, oranna@clearpassage.com
Web site: http://www.clearpassage.com/
Source: PRNewswire
Related Articles
- Republic of Korea Multiparameter Patient Monitoring Devices Market Report
- China Potassium Sulfate Market Study Research Report Provides Estimations and Analysis on China's Potassium Sulfate Market for 2007-2008
- Good Samaritan Hospital in the Top 5% in Women's Health According to HealthGrades(R) Study
- Cielo MedSolutions Offers Primary Care Practices On-Demand Patient Registries and Quality Reporting
- 'Womens Health - Female Sexual Dysfunction Drug Pipeline Report' Contains Detailed Information on the Current Drug Pipeline
- SinoFresh Reports Patient Case Study: Allergic Fungal Rhinosinusitis in Adult Male With History of Sinus Conditions
- Aspirin May Help Women Cut Heart Attack Risk, Study Says: Report in Today's JAMA Shows Preventive Potential for Both Sexes
- EMSYS Corporation Files A Patent Application For Its Patient Specific Radiation Therapy Billing System
- Genentech Stops Enrolling Patients in Study
- Xolair (Omalizumab) Add-On Therapy Significantly Reduces Attacks in Patients With Severe Allergic Asthma
User Comments (0)

RSS Feeds